| Symbol |
Name |
|
ACTN4
|
actinin, alpha 4
|
|
AGXT
|
alanine-glyoxylate aminotransferase
|
|
APRT
|
adenine phosphoribosyltransferase
|
|
AQP11
|
aquaporin 11
|
|
ARHGDIA
|
Rho GDP dissociation inhibitor (GDI) alpha
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BICC1
|
BicC family RNA binding protein 1
|
|
CCNI
|
cyclin I
|
|
CD151
|
CD151 molecule (Raph blood group)
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
COL4A3
|
collagen, type IV, alpha 3 (Goodpasture antigen)
|
|
COL4A4
|
collagen, type IV, alpha 4
|
|
DNASE1
|
deoxyribonuclease I
|
|
FAS
|
Fas cell surface death receptor
|
|
GLIS2
|
GLIS family zinc finger 2
|
|
GNE
|
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase
|
|
GRHPR
|
glyoxylate reductase/hydroxypyruvate reductase
|
|
HMOX1
|
heme oxygenase 1
|
|
INVS
|
inversin
|
|
LAMA5
|
laminin, alpha 5
|
|
LAMC1
|
laminin, gamma 1 (formerly LAMB2)
|
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
|
MPV17
|
MpV17 mitochondrial inner membrane protein
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NPHS2
|
nephrosis 2, idiopathic, steroid-resistant (podocin)
|
|
PAX2
|
paired box 2
|
|
PIK3C2A
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
POU3F3
|
POU class 3 homeobox 3
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
RRM2B
|
ribonucleotide reductase M2 B (TP53 inducible)
|
|
SLC12A1
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 1
|
|
TAL1
|
T-cell acute lymphocytic leukemia 1
|
|
TNS1
|
tensin 1
|
|
TXNIP
|
thioredoxin interacting protein
|
|
WNT4
|
wingless-type MMTV integration site family, member 4
|
|
WT1
|
Wilms tumor 1
|
|
WWTR1
|
WW domain containing transcription regulator 1
|
|
XDH
|
xanthine dehydrogenase
|
